Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 979 of 1,261
  1. US 7851465

    Compositions and methods relating to novel compounds and targets thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  2. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  3. EP 2257267

    WIRKSTOFFKOMBINATION UND IHRE VERWENDUNG

    AIR LIQUIDE SANTE INT [FR] · Granted Dec 8, 2010 · Expires Dec 3, 2030

    granted
  4. US 7846954

    Heterocyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  5. US 7846426

    Compositions and methods for treating and preventing cardiomyopathy and heart disease

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  6. US 7846450

    Melanoma associated peptide analogues and vaccines against melanoma

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  7. US 7846892

    Compositions and methods for Alzheimer's disease

    Primex Clinical Laboratories, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  8. US 7846431

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  9. US 7846466

    Biodegradable scaffolds and uses thereof

    Northwestern University · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  10. US 7847084

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  11. US 7846973

    Chemical process and new crystalline form

    Theravance, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  12. US 7846955

    Salt

    Argenta Discovery Limited · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  13. US 7846908

    RNAi modulation of TGF-beta and therapeutic uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  14. US 7846895

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  15. US 7846951

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  16. US 7846945

    Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  17. US 7846907

    Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  18. US 7846903

    Type II cubic liquid crystal composition

    KURARAY CO., LTD. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  19. US 7846675

    Truncated recombinant major outer membrane protein antigen (R56) of orientia tsutsugamushi strains karp, kato and gilliam and its use in antibody based detection assays and vaccines

    United States of America as represented by the Secretary of the Air Force · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  20. US 7846664

    Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

    The Regents of the University of California · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  21. US 7846690

    Cloning of honey bee allergen

    PLS-Design GmbH · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  22. US 7846455

    Attenuated chimeric respiratory syncytial virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  23. US 7846454

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  24. US 7842729

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.